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Abstract The potential of solid phase extraction (SPE)
clean-up has been assessed to reduce matrix effects (signal
suppression or enhancement) in the liquid chromatography-
tandem mass spectrometry (LC–MS/MS) analysis of
lipophilic marine toxins. A large array of ion-exchange,
silica-based, and mixed-function SPE sorbents was tested.
Polymeric sorbents were found to retain most of the toxins.
Optimization experiments were carried out to maximize
recoveries and the effectiveness of the clean-up. In LC–MS/
MS analysis, the observed matrix effects can depend on the
chromatographic conditions used, therefore, two different
HPLC methods were tested, using either an acidic or an
alkaline mobile phase. The recovery of the optimized SPE
protocol was around 90% for all toxins studied and no
break-through was observed. The matrix effects were
determined by comparing signal response from toxins spiked
in crude and SPE-cleaned extracts with those derived from
toxins prepared in methanol. In crude extracts, all toxins
suffered from matrix effects, although in varying amounts.
The most serious effects were observed for okadaic acid (OA)
and pectenotoxin-2 (PTX2) in the positive electrospray
ionization mode (ESI+). SPE clean-up on polymeric sorbents
in combination with the alkaline LC method resulted in a
substantial reduction of matrix effects to less than 15%
(apparent recovery between 85 and 115%) for OA, yesso-
toxin (YTX) in ESI− and azaspiracid-1 (AZA1), PTX2, 13-
desmethyl spirolides C (SPX1), and gymnodimine (GYM)
in ESI+. In combination with the acidic LC method, the
matrix effects after SPE were also reduced but nevertheless
approximately 30% of the matrix effects remained for PTX2,
SPX1, and GYM in ESI+. It was concluded that SPE of
methanolic shellfish extracts can be very useful for reduction
of matrix effects. However, the type of LC and MS methods
used is also of great importance. SPE on polymeric sorbents
in combination with LC under alkaline conditions was found
the most effective method.
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Introduction
Bivalves such as mussels, scallops, and oysters are filter-
feeding organisms that can accumulate marine biotoxins
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produced by certain algae. The most common intoxications
in Europe caused by the consumption of shellfish contam-
inated with marine toxins are diarrhetic shellfish poisoning
(DSP), and to a lesser degree, paralytic shellfish poisoning
(PSP). Toxins responsible for DSP intoxication belong to
the group of the lipophilic marine biotoxins. In this paper,
five different groups of lipophilic marine biotoxins are
considered: the first group is the already mentioned DSP
toxins of which the predominant toxins are okadaic acid
(OA), dinophysistoxin-1 (DTX1), dinophysistoxin-2
(DTX2), and dinophysistoxin-3 (DTX3) (Fig. 1a). DTX3
is a collective term for acyl-esterified forms of OA and
DTX1 and DTX2. DSP toxins cause diarrhea, nausea,
vomiting, and abdominal cramps [1, 2]. The second group
is the yessotoxins (YTXs; Fig. 1b). YTXs have an adverse
effect on the cardiac muscle cells in mice, but intoxications
in humans so far have not been reported [3, 4]. The third
group is the azaspiracids (AZAs; Fig. 1c), in which AZA1,
-2 and -3 are the predominant toxins. Azaspiracids show
adverse effects comparable to OA and DTXs; nausea,
diarrhea, stomach cramps, etc. Although the adverse effects
are comparable to those of DSP, the mode of action of
AZAs is different and only partially elucidated [5, 6]. The
fourth group is the pectenotoxins (PTXs; Fig. 1d). The
diarrhetic effects of PTXs are not clear and toxicity is only
observed after intraperitoneal injection in mice [7, 8]. The
fifth group is the spiroimine toxins; spirolides (SPXs) and
gymnodimine (GYM; Fig. 1e). These toxins show adverse
neurological effects on the respiratory tract, comparable
with saxitoxin (PSP toxin). The spiroimine toxins can cause
death of mice within minutes after intraperitoneal injection
[9].
EU regulation prescribes which lipophilic toxins should
be monitored and determined in the edible parts of shellfish
[10]. The permitted levels for the sum of OA, DTXs, and
PTXs is set at 160 µg kg−1, the sum of relevant YTXs is set
at a total of 1 mg kg−1 and the sum of relevant AZAs at
160 µg kg−1 [10]. The spiroimines are currently not
regulated under EU legislation, but may become regulated
in the future [11]. Mouse or rat bioassay is the official
control method for lipophilic marine toxins in shellfish
(alternative methods may be used if they provide an
equivalent level of shellfish consumer protection as
provided by the bioassay and have been validated to
international protocols). The animal assays have some
serious drawbacks with respect to sensitivity, detectability
of the individual toxins and in relation to animal welfare
and ethics. In recent years, analytical methods based on
liquid chromatography (LC) coupled to mass spectrometry
(MS) have been developed as an alternative for the
detection of lipophilic marine toxins in crude methanolic
shellfish extracts [12–15]. However, it is well known that in
LC–MS/MS analysis, matrix effects (ion suppression or ion
enhancement) can lead to an under- or overestimation of the
concentration. In order to overcome matrix effects, different
approaches can be used, including internal standards,
standard addition or the removal of matrix effects by
various clean-up techniques. Unfortunately, in the field of
Fig. 1 Structure of a okadaic acid and dinophysistoxins 1–3, b yessotoxin, c azaspiracids 1–3, d pectenotoxin-2, e 13-desmethyl spirolide C
(SPX1) and gymnodimine
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marine toxin analysis, internal standards are not available
yet. Ito et al. demonstrated that standard addition can be an
effective tool to eliminate matrix effects [16]. Due to the
scarcity of standards, the standard addition approach is
expensive and not generally feasible in routine analysis.
Different techniques have been tested for the clean-up of
methanolic shellfish extracts. Liquid–liquid extraction
(LLE) and solid phase extraction (SPE) are the clean-up
techniques most often used in the analysis of lipophilic
marine biotoxins. Various organic solvents have been used
for the LLE of the crude extracts [17–20]. After LLE, the
organic phase is evaporated to dryness and reconstituted in
methanol, acetonitrile, or acetone. The evaporation step
may have a negative effect on the solubility and stability of
the toxins. From a (pre-)validation round conducted within
the EU BIOTOX project, it became clear that LLE did not
give satisfactory results with respect to accuracy, reproduc-
ibility, and repeatability [21].
Most SPE methods are directed to the clean-up or isolation
of an individual toxin or toxin group. SPE clean-up has been
combined with LC-fluorescence detection (FLD) for the
determination of OA and DTXs in shellfish. Puech et al.
described the use of immuno-affinity cartridges with satisfac-
tory recoveries (>55%) [22] and Quilliam et al. used
aminopropylsilica cartridges with excellent recoveries
(>95%) [23]. For the determination of OA, DTX, YTX,
and PTX toxins with LC–MS, Goto et al. published a rather
labor- and resource-intensive method using two parallel SPE
procedures with recoveries in the range of 69–134% [24]. A
C18 cartridge was used to isolate YTX and 45OH-YTX from
the crude methanolic extract, while for the isolation of OA
and DTX1, LLE was applied, followed by SPE on a silica
cartridge. Stobo et al. used a polymeric type SPE cartridge to
isolate AZAs from crude extracts [13] and Moroney et al.
used a diol-type SPE sorbent for the clean-up of AZA1–3
from shellfish extracts [25], however, the effectiveness of the
clean-up has not been described in detail.
To our knowledge, there has not yet been a multi-toxin
SPE method developed that accommodates the predominant
lipophilic marine toxins from each of the five toxin groups.
In this paper, an SPE method is presented for the isolation
and clean-up of lipophilic marine toxins from all toxin
groups from crude methanolic extracts. The efficiency of
the SPE method in the removal of interfering matrix
components resulting in a reduction or removal of ion
suppression/enhancement effects was tested for three
different shellfish species: mussel, scallop, and oyster.
Recently, Fux et al. have shown that matrix effects can be
heavily dependent on the chromatographic system used
[26]. To study this in more detail, two separate LC–MS/MS
methods were applied, using very different mobile phase
systems [12, 27]. For OA and PTX2, the experiments were
also conducted with two electrospray ionization modes.
Experimental
Chemicals and standards
Water was deionized and passed through a Milli-Q water
purification system (Millipore, Billerica, MA, USA). Formic
acid (98–100%) was purchased from Merck, Darmstadt,
Germany. Ammonium formate (>97%) was purchased from
Sigma-Aldrich, Zwijndrecht, The Netherlands. Acetonitrile
(HPLC supra gradient) and methanol (absolute) were
purchased from Biosolve, Valkenswaard, The Netherlands.
Ammonium hydroxide (25%) was purchased from VWR
International, Amsterdam, The Netherlands. OA (certified
reference material (CRM)-OA-b 24.1±0.8 μg mL−1), YTX
(CRM-YTX 5.3±0.3 µg mL−1), AZA1 (CRM-AZA1 1.24±
0.07 µg mL−1), PTX2 (CRM-PTX2 8.6±0.3 μg mL−1), 13-
desmethyl spirolide C (SPX1) (CRM-SPX1 7.0±0.4 µg
mL−1) and gymnodimine (GYM) (CRM-GYM 5.0±0.2 µg
mL−1) were purchased from the National Research Council,
Institute for Marine Biosciences (NRC CNRC), Halifax,
Canada. A laboratory reference material (LRM) was pre-
pared from mussel (Mytilus edulis) containing OA, DTX1, -
2, YTX, AZA1, -2, -3 and PTX2 at the Marine Institute,
Ireland. An extract in methanol with a solvent-to-sample
ratio of 10 was prepared from this LRM homogenate.
Preparation of standard solutions and extracts
A stock solution containing a mixture of 320 ng mL−1 OA,
400 ng mL−1 YTX, 200 ng mL−1 AZA1 and 320 ng mL−1
PTX2 and a stock solution of 250 ng mL−1 SPX1 and
GYM was prepared in methanol. Blank mussel (M. edulis),
scallop (Pecten maximus) and oyster (Crassostrea gigas)
extracts were prepared by homogenizing 100 g of whole
flesh with a T25 Ultra Turrax mixer at 24,000 rpm (IKA®
Works Inc., Wilmington, NC, USA). 2 g of this shellfish
homogenate was extracted in triplicate with 6 mL methanol.
After each addition of methanol the extract was vortex
mixed during 1 min, after which the extract was
centrifuged 5 min at 2000 g. The methanolic extracts
were combined in a 20 mL volumetric flask, and the
volume was made up to 20 mL with methanol. The crude
shellfish extract was filtered through a 0.2 µm high
temperature (HT) resistance Tuffryn membrane filter (Pall
Corp., East Hills, NY, USA) prior to spiking. The crude
methanolic extract was spiked at a concentration of
16 ng mL−1 OA (equivalent to 160 µg kg−1 OA), 20 ng
mL−1 YTX (equivalent to 200 µg kg−1 YTX), 10 ng mL−1
AZA1 (equivalent to 100 µg kg−1 AZA1) and 16 ng mL−1
PTX2 (equivalent to 160 µg kg−1 PTX2). In an additional
experiment the same crude blank mussel extract was
spiked with 12.5 ng mL−1 SPX1 and GYM (equivalent to
125 µg kg−1 SPX1 and GYM).
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Liquid chromatography
An Alliance 2690 (Waters, Milford, MA, USA) HPLC
system was used in combination with a Thermo Electron
BDS Hypersil™ C8 (50×2.1 mm, 3 µm) column and with a
Waters X-Bridge™ C18 (150×3 mm, 5 µm) column. For
both columns the temperature was set at 40 °C.
The Hypersil column was used under acidic conditions
(pH 2.6). Mobile phase Awas water and B was acetonitrile/
water (95:5% v v−1), both containing a fixed concentration
of 2 mM ammonium formate and 50 mM formic acid. A
gradient was run at a flow rate of 0.2 mL min−1; it started
with 30% B, which was increased linearly to 90% B in
8 min. The composition was kept for 2.5 min at 90% B and
was in 0.5 min returned to 30% B. An equilibration time of
4 min was allowed before the next injection.
The X-Bridge™ column was used under alkaline
conditions (pH 11) with water as mobile phase A and
acetonitrile/water (90:10% v v−1) as mobile phase B. Both
mobile phases contained 6.7 mM ammonium hydroxide. A
gradient was run at a flow rate of 0.4 mL min−1; the
gradient started with 10% B, which was after one min
increased linearly to 90% B in 9 min. The composition was
kept at 90% B for 3 min and was in 2 min returned to 10%
B. An equilibration time of 4 min was allowed before the
next injection. For both the acidic and alkaline LC method,
the vial compartment of the autosampler was kept at 10 °C
and a 10-µL injection volume was used.
Mass spectrometry
Mass spectrometry was performed using a Micromass
Quattro Ultima tandem mass spectrometer (Waters-Micro-
mass, Manchester, UK) equipped with an electrospray
ionization interface (ESI). The mass spectrometer was
operated in the negative ESI (ESI−) and the positive ESI
(ESI+) mode, with a capillary voltage of 2.8 kV, a
desolvation temperature of 350 °C at a nitrogen gas flow
rate of 600 L h−1, a source temperature of 120 °C, and a
cone gas flow rate of 100 L h−1. Argon was used as
collision-induced dissociation (CID) gas at a pressure of
2.3×10−3 mbar. The cone voltage and collision energy were
optimized by direct infusion experiments under acidic and
alkaline conditions (Table 1). For both LC gradients
negative and positive ionization were applied in separate
runs. OA and PTX2 were analyzed in both the ESI− and
ESI+ mode while YTX was analyzed only in the ESI− mode
and AZA1, SPX1, and GYM only in the ESI+ mode,
Toxin ESI mode Precursor (m/z) Product (m/z) Cone (V) Collision energy (eV)
OA ESI− [M-H]− 803.5 113.1 60 50
151.1 60 50
255.2 60 45
ESI+ [M+Na]+ 827.5 723.3 70 45
791.4 70 45
809.3 70 45
YTX ESI− [M-H]− 1141.5 1061.5 45 40
ESI− [M-2H]2- 570.4 396.4 75 40
467.4 75 40
AZA1 ESI+ [M+H]+ 842.5 654.4 35 40
672.4 35 40
824.5 35 30
PTX2 ESI− [M-H]− 857.4 137.2 90 45
155.2 90 45
179.2 90 45
PTX2 ESI+ [M+NH4]
+ 876.5 213.1 40 30
805.5 40 30
823.5 40 30
SPX1 ESI+ [M+H]+ 692.5 164.3 40 50
444.2 40 40
674.4 40 30
GYM ESI+ [M+H]+ 508.2 121.4 50 45
162.2 50 45
490.2 50 25
Table 1 Multiple reaction
monitoring (MRM) acquisition
parameters for the selected
lipophilic marine toxins
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respectively. For the acidic and alkaline LC method a
solvent delay of respectively 2 and 3 min was used to
reduce contamination of the MS interface.
Solid phase extraction
Automated SPE system (Symbiosis Pharma)
Development of the SPE procedure was performed using an
array of cartridges and sorbents from different manufac-
turers. Due to a very limited availability of standards,
optimization of the SPE method was carried out using the
LRM extract. SPE sorbent screening was performed with an
automated SPE system, the Symbiosis Pharma (Spark
Holland, Emmen, The Netherlands). The Symbiosis
Pharma consists of a temperature-controlled stacker, a
temperature-controlled autosampler (Reliance), a high-
pressure dispenser (HPD single), a high-pressure mix with
a solvent-selection manifold, a gradient pump set, and an
automatic cartridge exchanger (ACE). With the Symbiosis
Pharma, the following sorbents were tested: Cyano, C2, C8,
C8 endcapped (C8 ec), C18, C18 high definition (C18 HD),
general purpose resin (GP) and strongly hydrophobic resin
(SH), all cartridges containing 12.5 mg sorbent from Spark
Holland, Emmen, The Netherlands, and weak cation-
exchange (WCX), strong cation-exchange (MCX), weak
anion-exchange (WAX) and strong anion-exchange (MAX)
cartridges containing 2.5 mg sorbent from Waters, Etten-
leur, The Netherlands (Table 2).
All cartridges were conditioned with 1 mL methanol
and equilibrated with 1 mL 30% v v−1 methanol/water.
The crude methanolic shellfish extract was diluted with
water to an organic strength of 30% v v−1 methanol/water
and 25 µL of the diluted extract was automatically
transferred to the top of the cartridge. The Cyano, C2,
C8, C8 ec, C18, C18 HD, GP, and SH cartridge were
washed with 1 mL 20% v v−1 methanol/water and
subsequently eluted with 500 µL methanol/water contain-
ing 1% v v−1 ammonium hydroxide (25%). The ion-
exchange cartridges (WCX, MCX, WAX, and MAX) were
washed with 1 ml 5% v v−1 ammonium hydroxide (25%)
in water, 30% v v−1 methanol/water or 2% v v−1 formic
acid in water. Elution was carried out with 500 µL 5%
v v−1 ammonium hydroxide (25%) in methanol, methanol
or 2% v v−1 formic acid in methanol. The Symbiosis SPE
extracts were analyzed by LC–MS/MS using the alkaline
LC gradient.
Initially selected SPE protocol
In order to optimize the off-line SPE, two different
cartridges containing polymeric sorbents were used:
60 mg 3 mL Oasis® HLB (Waters, Etten-leur, The Nether-
lands) and 60 mg 3 mL Strata™-X (Phenomenex, Torrance,
CA, USA). The retention capacity of both cartridges was
investigated by application of LRM extract diluted before
application with 60% water. The cartridges were subse-
quently washed with 50% v v−1 methanol and eluted with
methanol. The wash and elution solvents and volumes were
optimized during the method development stage for the
cartridge with the best retention capacity. Furthermore,
break-through, wash losses, and recoveries, based on the
mass spectrometric analysis of the toxins present in the
LRM material, before and after SPE clean-up were
determined. Based on the results obtained the final SPE
protocol was defined.
Final SPE protocol
After further optimization (see “Optimization of the SPE
clean-up protocol” section) a 30 mg 1 mL Strata™-X
cartridge was selected. It was activated with 1 mL of
methanol. Prior to application of the sample, the cartridge
was equilibrated using 1 mL 30% v v−1 methanol. Crude
methanolic shellfish extract (1.2 mL) was diluted with
2.8 mL water and applied on the cartridge. The cartridge
was washed with 1 mL 20% v v−1 methanol in order to
remove polar compounds. Finally the toxins were eluted
from the cartridge using 1.2 mL methanol containing 0.3%
v v−1 ammonium hydroxide. The purified extracts were
transferred to an HPLC vial and analyzed by LC–MS/MS.
Various parameters were investigated (Fig. 2). The
recovery of the SPE clean-up step was determined by
comparing the MS response of individual toxins spiked to
the crude extract pre-SPE with the same toxins spiked to
the purified extract post SPE. Secondly, the matrix effect
observed for each toxin in the crude extract was
determined for both LC gradients by comparing the toxins
spiked to crude extract with the toxins spiked to methanol.
In the same way, the matrix effects observed in the
purified extracts, obtained after SPE, were determined by
comparing the purified extract with the toxins spiked to
methanol. Finally, the apparent recovery, defined as the
combination of the (reduced) matrix effect and the recovery
of the SPE was established by comparing the pre-SPE toxin-
spiked extracts with the toxins spiked to methanol. All
experiments were repeated five times for each matrix, the
results were based on the total area of three transitions,
except for YTX where under acidic conditions one
transition was used (Table 1). At low pH, the predominant
precursor ion was the single charged molecule at m/z
1,141.5 [M-H]−, while at high pH, the predominant
precursor was the doubly charged molecule [M-2H]2−, at
m/z 570.4. Therefore, the [M-H]− ion was used with the
acidic LC conditions and the with the [M-2H]2− with the
alkaline LC conditions.
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Results and discussion
Initial method development
The first step of the SPE method development focused on
finding an appropriate sorbent which retained the various
toxin groups. With the Symbiosis Pharma system, a rapid
sorbent screening of 12 different sorbents ranging from
very polar to strongly hydrophobic was performed (see
Table 2 for the chemistry of the sorbents). On most
cartridges, retention may be expected based on the
lipophilic character of the toxins tested. Additional reten-
tion due to the presence of ionizable functional groups may
play an important role when ion-exchange cartridges are
used.
Based on the chemistry of the ion-exchange sorbents, a
prediction could be made for the interaction of the various
toxins with these sorbents, indicating the difficulties to be
expected in finding an appropriate sorbent which will retain
all lipophilic marine toxins. To study the retention of the
toxins on the various ion-exchange sorbents, the cartridges
were washed and eluted with alkaline, neutral, and acidic
solutions. All wash and elution combinations were tested
per ion-exchange cartridge. In this way, the cartridges were
also used in their non-ideal or even opposite polarity of
wash and elution conditions. OA, which contains a
Table 2 Sorbents tested for clean-up of marine lipophilic toxins
Type of cartridge Structure 
Silica Cyano (CH2)3Si C N
 
 C2 Si CH2 CH3
 
 C8 and C8 ec Si (CH2)7 CH3
 
 C18 and C18 HD Si (CH2)17 CH3
 
   R 
Ion exchange WCX 
COOH 
 MCX 
SO3-
 
 WAX 
N
NH
 
 MAX 
N
O
R
 
N+
 
   
Polymer SH 
 
 GP CH3
CH3
CH3
CH3
 
 HLB 
N
O
 
 StrataTM-X 
N
O
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carboxylic acid group, was very well retained on the MAX
cartridge as expected; but also the WAX cartridge (specific
for strong acids) yielded a high recovery under most of the
applied wash and elution conditions, with the exception of
the alkaline wash and acidic elution (<25%; Fig. 3). YTX
contains two sulfonic acid groups and should be retained on
a WAX cartridge. Good recoveries on the WAX cartridge
were obtained for YTX, when a neutral or acidic wash was
applied in combination with alkaline elution (Fig. 3).
However, the recovery for YTX was poor on the MAX,
WCX, and MCX cartridge regardless of the conditions
applied. AZA1 is an amphoteric compound containing a
carboxylic acid as well as an amino group, and could be
retained on the MAX as well as on the MCX cartridge. The
MAX cartridge gave good recoveries for AZA1 with an
alkaline wash followed by acidic elution and with a neutral
wash and basic elution. Furthermore, reasonable recoveries
were obtained for AZA1 on the MCX and WCX cartridge
with an acidic or neutral wash and neutral or alkaline
elution (Fig. 3). SPX1 and GYM contain an imine group
which should be retained best on an MCX cartridge.
However, SPX1 was also well retained on the WCX
cartridge under most conditions (Fig. 3). PTX2, a neutral
compound, does not contain any specific functional groups.
For this reason, it is difficult to predict its behavior on the
different cartridges. In practice, PTX2 had some retention
on all cartridge types. The best recoveries were obtained on
the MAX and WCX cartridges under acidic wash con-
Fig. 3 Sorbent screening of
different ion-exchange
cartridges using the Symbiosis
Pharma automated SPE system.
Highest signal intensity per
individual toxin set at 100%
(n=2)
Fig. 2 Flowchart of the investi-
gated parameters of the SPE
clean-up
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ditions. Reasonable recoveries were obtained on the MAX
and WAX cartridges using an alkaline wash and acidic
elution.
Figure 3 shows that only in two instances (MAX and
WAX with acidic wash and alkaline elution) two out of five
toxins were retained with high efficiency (>90%). Only on
one occasion (WAX cartridge with a neutral wash and
neutral elution step), four out of five toxin groups could be
recovered with more than 50% yield. It is evident that it
will be very difficult to find an ion-exchange cartridge and
the appropriate wash and elution conditions at which for all
five toxin groups good recoveries are obtained.
With respect to the silica-based sorbents that were tested
with the Symbiosis Pharma system, OA gave good
recoveries on all the cartridges that were investigated, with
the exception of the CN cartridge (Fig. 4). For YTX, good
recoveries were obtained with the C18 HD and GP
cartridge, while AZA1 showed good recoveries on all the
cartridges except on the SH cartridge. The recovery of
PTX2 was good on all cartridges with the exception of the
CN cartridge. From the data shown in Fig. 4, it is clear that
the C18 HD and GP cartridges showed overall the best
recoveries of the five toxin groups.
In conclusion, for the ion-exchange and silica-based
cartridges and for each toxin different optimum conditions
and different optimal sorbents were obtained. Especially for
YTX, it was difficult to find suitable conditions that would
match with the other toxins. As none of the cartridges dealt
with above is capable to retain all five toxin groups, the
focus changed towards general purpose polymeric car-
tridges. These polymeric cartridges can be applied for a
broad range of compounds. Two different brands of
polymeric sorbents were selected for further investigation,
Oasis® hydrophilic lipophilic balance (HLB) and Strata™-
X. Because the Strata™-X cartridge was not available for
the Symbiosis Pharma system, further optimization experi-
ments were performed off-line. With polymeric cartridges
such as Oasis® HLB and Strata™-X retention of com-
pounds is based on their polar and lipophilic interactions.
Optimization of the SPE clean-up protocol
In comparison with the previous tested sorbents (ion-
exchange and silica) the polymeric cartridges are capable
to retain all the lipophilic marine toxin groups. From Fig. 5
it can be seen that OA, DTX1, DTX2, and YTX retained
20–50% better on the Strata™-X than on the Oasis® HLB
cartridge during the application and wash step. AZA1, -2, -
3, and PTX2 were retained 5–10% better on the Oasis®
HLB cartridge. Overall, Strata™-X performed better.
Therefore, the Strata™-X cartridge was used for further
optimization experiments. Volume and organic solvent
strength of the applied crude extract, wash step, and elution
step were optimized.
Solvent strength of crude extract
The volume and organic solvent strength of the crude
shellfish LRM extract tolerated during application on the
Strata™-X cartridge was investigated. No break-through
was observed when the crude methanol extracts (2 mL)
were diluted to 30% v v−1 methanol in water prior to
application to the SPE cartridge. At a higher percentage,
methanol (40%, 50%, 60% v v−1 methanol in water) break-
through of OA, DTX1, DTX2, and YTX was observed.
Increasing volumes of crude sample extract (up to 6 mL
diluted to 30% v v−1 methanol by mixing with 14 mL
water) were applied to the 60 mg cartridge. In none of the
extracts was break-through of any of the toxins observed.
Thus, if necessary, a concentration step can be incorporated
into the extraction protocol.
Wash step
The organic solvent strength of the wash step (3 mL) was
optimized by using 0–70% v v−1 methanol/water mixtures
with increments of 10%. OA, DTX1, DTX2, and YTX
started to elute (less than 3%) when wash solutions were
used with more than 30% methanol. AZAs were retained on
the cartridge with up to 50% methanol and PTX2 did not
elute even with 70% methanol. A wash step of 20% v v−1
methanol/water was incorporated to avoid losses during
washing.
Next, the effect of using acidic, neutral, or alkaline 20%
v v−1 methanol/water as wash solvent was investigated. The
acidic wash solvent contained 1% v v−1 formic acid and the
Fig. 4 Sorbent screening using the Symbiosis Pharma automated SPE
system. Highest signal intensity per individual toxin set at 100%.
Wash with 20% v v−1 methanol/water elution with 1% v v−1 NH4OH
in methanol
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alkaline wash solvent 1% v v−1 ammonium solution. As no
significant differences in recovery of the toxins were
obtained between the various wash solvents, a neutral wash
step of 20% v v−1 methanol/water was incorporated in the
final method.
Elution step
Elution was performed with 2 mL methanol. To estimate
the amount of remaining toxins on the cartridge a second
elution step with 2 mL methanol, collected in a second vial,
was incorporated. The first elution resulted in an almost
complete recovery (>90%) of OA, DTX1, DTX2, AZA1,
AZA2, AZA3, and PTX2 but for YTX, the recovery was
somewhat lower (60–70%). Around 10–20% of YTX was
eluted in the second step. The recovery of YTX correlated
with the pH of the wash step used during clean-up. With an
alkaline wash step, the recovery of YTX was higher (80–
90%), while with an acidic wash step, it was lower (50–
60%). By adding 0.3% v v−1 ammonia solution to the
elution solvent, the recovery could be increased to around
90% for YTX without affecting the recoveries of the other
toxins. Using higher concentrations of ammonia did not
further improve recoveries.
The stability of the toxins under alkaline conditions in
the presence of ammonia has been investigated previously
[12]. No degradation of any of the toxins was observed
even at concentrations of 12.5% v v−1 ammonia in water.
Performance of the optimized protocol
All optimization experiments were conducted with
60 mg Strata™-X cartridges. Although this may be a
very practical size to be used in routine monitoring of
shellfish samples it was decided to downscale the
procedure to 30 mg cartridges in order to save valuable
toxin standards.
To study the efficacy of the optimized SPE protocol
with respect to recovery and matrix effects, methanolic
extracts with a solvent-to-sample ratio of 10, from blank
mussels, scallops, and oysters were spiked with OA,
YTX, AZA1, and PTX2. In a second experiment, SPX1
and GYM were spiked to a blank mussel extract to
check if the developed method could also be applied for
these toxins as well. Toxin concentrations were chosen
such that they were at (16 ng mL−1 OA and PTX2) or
somewhat below (20 ng mL−1 YTX and 10 ng mL−1
AZA1) the current permitted level in EU legislation [10].
For SPX1 and GYM, there is currently no legislation
established. These toxins were added to the mussel extract
at a concentration of 12.5 ng mL−1.
It was anticipated that the chromatographic conditions
used prior to MS detection can be of importance to the
observed matrix effects [26]. Changing the pH of the
mobile phase may lead to an altered separation of toxins
and matrix components. To investigate the effect of
chromatographic separation, two different established
HPLC methods were used [12, 28], one using acidic
conditions and the other one alkaline conditions. As was
shown before, the elution profile of the toxins is quite
different under these conditions [12].
The ion ratios of the various transitions were reproduc-
ible with RSDs lower than 15% (n=70, data not shown).
The only exception was PTX2 analyzed in the ESI− mode
in combination with the acidic LC method. Due to an
eightfold-lower sensitivity, compared to ESI+, an RSD of
around 25% was obtained.
Recovery of the SPE method
The SPE clean-up procedure using Strata™-X cartridges
worked well for OA, YTX, AZA1, PTX2, SPX1, and GYM
yielding good to excellent recoveries (Tables 3, 4, and 5).
The average recovery of all toxins and matrices combined
was good, 90.0±6.0% as determined with the alkaline LC
gradient, and 92.6±6.9% with the acidic LC gradient. For
individual toxins the recovery varied between 74.6±2.9%
for YTX in oyster extract (as determined by the alkaline LC
gradient method) and 102.9±10.7% for OA in oyster
extract (measured in ESI− with the acidic gradient). In
general, the relative standard deviations (RSD) obtained
with the alkaline method (max. 12.5% for GYM) were
better compared to those of the acidic method (max. 22.3%
for AZA1). Ideally, the recoveries calculated with both
methods should not be significantly different, because the
recovery of the SPE should not be influenced by the
chromatographic system used. Indeed, most of the recov-
Fig. 5 Relative intensity of selected toxins on two different sorbents
with the preliminary SPE protocol. Highest intensity per individual toxin
is set at 100%.Wash with 50% v v-1 methanol and elution with methanol
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eries obtained were not significantly different (p≤0.05)
with both methods, with the exception of OA (ESI−) in
mussel and in oyster and YTX in oyster. For OA, no
explanation can be given for the differences in the recovery
obtained. For YTX, the differences in recovery can be
explained by the peak shape of YTX that was rather poor
under acidic conditions, which hampered an accurate
integration of ion signals (Fig. 6).
Table 3 Performance parameters of the optimized SPE protocol for mussel extracts
Toxin Ionization LC conditions Recovery SPE (%) Percentage matrix effects Apparent recovery (%)
Crude (%) After SPE (%)
Avg (n=5) RSD Avg (n=5) RSD Avg (n=5) RSD Avg (n=5) RSD
OA ESI− Alkaline 90.0 6.4 99.3 3.8 104.9 4.4 94.5 6.0
Acidic 102.5 4.7 104.7 8.1 106.9 7.5 109.5 8.4
OA ESI+ Alkaline 93.6 4.8 23.8 8.4 61.3a 8.2 57.3a 7.5
Acidic 92.5 10.1 61.1 12.8 119.2a 14.1 110.3a 16.0
YTX ESI− Alkaline 90.0 4.7 95.4 4.6 109.9 5.0 99.0 5.3
Acidic 93.2 8.3 124.9 14.5 122.4 19.4 114.0 20.7
AZA1 ESI+ Alkaline 88.6 3.5 88.1 5.7 98.2a 6.5 86.9 5.8
Acidic 85.5 22.3 84.3 10.3 105.6a 9.6 90.2 23.3
PTX2 ESI− Alkaline 89.3 5.3 64.7 8.0 101.1a 5.9 90.3a 5.6
Acidic 95.5 17.4 105.9 16.0 106.8 19.4 102.0 20.2
PTX2 ESI+ Alkaline 90.0 3.9 56.5 5.3 86.7a 5.3 78.0a 5.5
Acidic 89.0 8.4 139.5 7.7 128.1 11.4 114.0a 13.0
SPX1 ESI+ Alkaline 100.7 11.6 89.4 5.0 95.6 10.3 96.2 7.8
Acidic 96.3 13.4 95.7 6.0 64.9b 11.6 62.6b 8.8
GYM ESI+ Alkaline 96.9 12.5 81.1 6.4 95.8a 11.3 92.9a 9.0
Acidic 89.0 9.8 92.5 4.5 70.3b 9.4 62.5b 5.4
Numbers given in italics: when RSD above 15% or when recovery, crude, after SPE or apparent recovery are below 85% or above 115%
a Significantly improved compared to crude extract (p≤0.05)
b Significant deterioration compared to the crude extract (p≤0.05)
Table 4 Performance parameters of the optimized SPE protocol for scallop extracts
Toxin Ionization LC conditions Recovery (%) Percentage matrix effects Apparent recovery (%)
Crude (%) After SPE (%)
Avg (n=5) RSD Avg (n=5) RSD Avg (n=5) RSD Avg (n=5) RSD
OA ESI− Alkaline 93.6 3.2 98.9 4.7 104.4 5.1 97.8 4.3
Acidic 102.3 9.7 128.8 10.6 85.5a 12.5 87.5a 11.2
OA ESI+ Alkaline 85.8 4.2 17.6 19.3 101.2a 14.3 86.9a 14.6
Acidic 91.9 11.3 203.1 19.9 115.4a 19.9 106.1a 19.9
YTX ESI− Alkaline 88.5 3.6 98.2 6.0 113.5 6.2 100.4a 5.5
Acidic 94.8 10.2 105.9 11.8 99.0 13.0 93.9 13.0
AZA1 ESI+ Alkaline 86.4 3.0 89.0 4.9 102.8a 4.4 88.8 5.0
Acidic 86.4 7.2 59.1 35.9 80.0 14.5 69.1 13.9
PTX2 ESI− Alkaline 89.9 4.7 56.7 7.9 88.7a 6.7 79.7a 7.0
Acidic 94.2 17.2 115.6 17.6 90.5 18.0 85.3 12.2
PTX2 ESI+ Alkaline 90.1 2.8 71.1 5.1 94.1a 4.9 84.8a 5.0
Acidic 88.5 8.7 128.4 9.9 111.4 10.2 98.6a 9.3
Numbers given in italics: when RSD above 15% or when recovery, crude, after SPE or apparent recovery are below 85% or above 115%
a Significantly improved compared to crude extract (p≤0.05)
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Matrix effects in the crude and SPE-purified extracts
In the crude scallop and oyster extracts substantial ion
enhancement was found for OA when run with the acidic
method (Tables 4 and 5). The ion enhancement for OA in
the scallop extract was as high as 103% in ESI+ and 29% in
ESI−. For OA, when extracts from the different shellfish
matrices were analyzed with the alkaline LC gradient
severe signal suppression of up to 70–80% was observed
in ESI+, but only minor suppression (<20%) was observed
in ESI− (Tables 3, 4, and 5). The SPE clean-up reduced the
signal enhancement for OA in the samples analyzed under
acidic conditions to less than 20% in ESI+ with a large
relative standard deviation of 22.8% and in ESI− the matrix
effect was reduced to <15% with RSDs below 15%. With
the alkaline method, only minor ion suppression or
enhancement (<10%) was observed, except for mussel
and oyster extracts for which severe suppression (40–50%)
was found in ESI+. In ESI+, enhancement and suppression
effects for OA are stronger than in ESI−. This is true for
both applied methods, but especially for the alkaline
method for which significant suppression is observed after
SPE clean-up. OA, DTX1, and DTX2 are, therefore,
preferably analyzed in the ESI− mode.
For YTX, only moderate matrix effects were observed in
the crude extracts (Tables 3, 4, and 5). The largest effect
was observed for the mussel extract run under acidic
conditions resulting in 25% ion enhancement. Under
alkaline conditions, the oyster extract gave 20% ion
suppression for YTX. SPE clean-up contributed to a
reduction of the suppression and enhancement effects for
YTX in the various extracts to 15% for both LC gradients.
The only exception was the mussel extract analyzed with
the acidic gradient, for which an enhancement of around
20% was found. For YTX, significantly smaller RSDs were
Table 5 Performance parameters of the optimized SPE protocol for oyster extracts
Toxin Ionization LC conditions Recovery (%) Percentage matrix effects Apparent Recovery (%)
Crude (%) After SPE (%)
Avg (n=5) RSD Avg (n=5) RSD Avg (n=5) RSD Avg (n=5) RSD
OA ESI− Alkaline 85.8 5.0 79.6 7.0 93.4a 7.1 80.1 7.0
Acidic 102.9 10.7 123.6 9.5 90.9a 13.6 93.6a 15.3
OA ESI+ Alkaline 94.4 5.2 19.0 9.5 44.9a 10.0 42.4a 9.7
Acidic 94.1 6.7 140.5 22.9 117.7 22.8 110.7 22.3
YTX ESI− Alkaline 74.6 2.9 80.3 4.9 103.9a 5.2 77.6 5.2
Acidic 89.7 10.8 109.7 11.8 97.0 12.2 86.9 12.0
AZA1 ESI+ Alkaline 84.1 3.8 83.5 3.8 100.6a 3.6 84.6 4.5
Acidic 78.2 7.2 73.6 10.7 83.7 7.5 65.5 7.6
PTX2 ESI− Alkaline 93.1 6.6 67.7 13.4 114.2a 11.9 106.2a 11.9
Acidic 101.6 11.5 106.2 12.9 85.2 14.1 86.6 15.7
PTX2 ESI+ Alkaline 94.3 5.4 85.4 5.4 102.9a 5.1 97.0a 4.9
Acidic 89.1 7.2 140.2 10.8 131.8 11.7 117.4 12.4
Numbers given in italics: when RSD above 15% or when recovery, crude, after SPE or apparent recovery are below 85% or above 115%
a Significantly improved compared to crude extract (p≤0.05)
Fig. 6 Analysis of toxins under a acidic conditions and b alkaline
conditions by LC–MS/MS
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obtained with the alkaline method (5.0–6.2%) than with the
acidic method (12.2–19.4%). This can be attributed to the
fact that the peak shape of YTX is much better under
alkaline conditions [28].
Suppression effects for AZA1 in the crude extracts
were in the order of 20–40% with the acidic, and 10–
20% with the alkaline method. After SPE clean-up, still
some suppression (20% in scallop extracts) was found
with the acidic gradient while with the alkaline gradient
the suppression was reduced to <5%. For both methods,
the relative standard deviations obtained were good
(<15%) except for the crude scallop extract analyzed
under acidic conditions (RSD 35.9%).
For PTX2, the differences in observed matrix effects in
the crude extracts between ESI+ and ESI− were not as large
as for OA. When analyzed under acidic conditions and in
ESI+, PTX2 showed signal enhancement of around 40%,
while in ESI− minor enhancement was observed (<15%).
When applying the alkaline method, significant ion suppres-
sion was observed for PTX2 with both ESI modes, ranging
from 15% for oyster in ESI+ to 43% for the scallop extract in
ESI−. In the purified extract, PTX2 revealed ion enhance-
ment of 20–30% in ESI+ under acidic conditions, while in
ESI− minor enhancement was observed (<15%). Relatively
high relative standard deviations of more than 15% were
obtained in ESI−, which can be explained by the low
sensitivity of PTX2 in ESI−. The basic gradient largely
removed the matrix effects resulting in ion suppression or
enhancement effects of less than 15% for all matrices in ESI+
and ESI−. Differences in matrix effects observed between the
two gradients can be explained by the fact that the alkaline
gradient is probably such that the toxin elution occurs
outside the elution of the majority of the matrix constituents
resulting in less ion suppression and enhancement effects.
In the crude mussel extract, only minor suppression
occurred for SPX1 and GYM with both gradients (<15%).
Surprisingly, for the extract analyzed after SPE the suppres-
sion increased to 35% with the acidic conditions, while for
the alkaline method the suppression remained minimal at less
than 5%. It can be concluded that SPE clean-up resulted in
the reduction of matrix effects for most toxins studied.
However, the amount of reduction was variable and
depended on the chromatographic conditions used. Overall,
the clean-up was more efficient and more reproducible in
combination with the alkaline method. As shown in Tables 3,
4, and 5 most toxins analyzed with the alkaline gradient gave
a significant (p≤0.05) reduction in matrix effects after SPE
clean-up compared to the crude extracts.
Apparent recovery of the SPE method
The apparent recovery, defined as the combined effect of
the SPE recovery and the remaining matrix effects is shown
in Tables 3, 4, and 5. In general, an improvement was
obtained when the apparent recoveries were compared with
the corresponding recoveries obtained from the crude
extracts indicating the beneficial effect of applying SPE
clean-up for the removal of matrix components likely to
induce suppression effects. For the acidic gradient, the
apparent recovery varied between 62.5% for SPX1 and
GYM in mussel and 117.4% for PTX2 in the oyster extract.
For the alkaline method, the apparent recovery varied
between 77.6% for YTX in oyster and 100.4% for YTX in
the scallop extract. Furthermore, the RSDs obtained with
the alkaline method were significantly better than with the
acidic method.
In order to improve the apparent recovery, the apparent
recovery should be corrected for the loss of toxins
encountered during SPE. There are several methods to
correct for these losses. First, a correction factor matching
the loss of recovery could be used, which should be
determined during validation of the method. The second
option is to use matrix-matched standards. When these
matrix-matched standards are applied to the SPE proce-
dure, they would give the correction for the recovery of
the SPE step.
In general, the overall recovery of the SPE clean-up
combined with the alkaline method was more reproducible
than with the acidic method.
Conclusion
The SPE clean-up using Strata™-X cartridges resulted in
reduced matrix effects when both acidic and alkaline LC
gradients were applied. Moreover, when SPE was used in
combination with the alkaline method the matrix effects
after SPE were reduced to less than 15% for all toxins
analyzed in their preferred mode regardless of the matrix
used. For the acidic method, differences in matrix effects
were less substantial between the crude extract and extract
after SPE. The matrix effects obtained in crude mussel
extracts were in accordance with the results obtained by
Fux et al. [26]. Only for two toxins (OA and AZA1) in
purified mussel extract were the matrix effects less than
15%. In the present study, the observed RSDs of the results
were much smaller with the alkaline method as well
(<15%).
When the apparent recovery is compared to the crude
extract, a significant improvement (p≤0.05) was only
obtained for a few toxins (Tables 3, 4, and 5). At first
sight, one could consider not to implement the SPE
procedure. The loss of toxins encountered during SPE
(average recoveries around 90%) attributed to this modest
improvement in apparent recovery. However, when the
crude extract and the extract after SPE were compared, a
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significant reduction (p≤0.05) in matrix effects was
obtained for most toxins analyzed by the alkaline method
(OA ESI+, AZA1, PTX2 ESI+ and ESI−, and GYM) and for
some analyzed with the acidic method (OA ESI+, and
AZA1).
The detection limits of the alkaline and acidic method is
as previously published well below the current legislation
[12].Therefore, small losses obtained during the SPE will
not lead to sensitivity issues during the analysis of marine
lipophilic toxins at the current established levels.
Differences observed between the acidic and alkaline
chromatographic conditions after SPE clean-up using
Strata™-X indicate that the clean-up could possibly still
be further improved. This will, however, not be easy
because the large range of lipophilicities involved. Analysis
of single-toxin groups and after selective SPE clean-up
could be considered as an alternative, but obliviously only
at the expense of increased analytical turnaround times. The
use of the Symbiosis Pharma system for the automated
screening of various SPE sorbents was advantageous in this
study. With this system, the testing of sorbents including
the testing of various wash and elution solvents could be
done more effectively compared to the time consuming
offline optimization experiments. In summary, this study
showed that the use of branded, polymeric SPE sorbents for
shellfish extract clean-up has the efficiency to reduce
deleterious matrix constituents whilst, in most toxin/
shellfish matrix combinations, maintaining satisfactory
reproducible recoveries.
Acknowledgment This research was undertaken with the financial
support of the European Commission, within the 6th Framework
project ‘BIOTOX: Development of cost-effective tools for risk
management and traceability systems for marine biotoxins in seafood’
Contract no: 514074 (www.biotox.org).
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Yasumoto T, Murata M (1993) Marine toxins. Chem Rev
93:1897–1909
2. Toyofuku H (2006) Joint FAO/WHO/IOC activities to provide
scientific advice on marine biotoxins (research report). Mar Pollut
Bull 52:1735–1745
3. Terao K, Ito E, Oarada M, Murata M, Yasumoto T (1990)
Histopathological studies on experimental marine toxin poison-
ing. 5. The effects in mice of yessotoxin isolated from
Patinopecten yessoensis and of a desulfated derivative. Toxicon
28:1095–1104
4. Aune T, Sorby R, Yasumoto T, Ramstad H, Landsverk T (2002)
Comparison of oral and intraperitoneal toxicity of yessotoxin
towards mice. Toxicon 40:77–82
5. Twiner MJ, Hess P, Dechraoui MYB, McMahon T, Samons MS,
Satake M, Yasumoto T, Ramsdell JS, Doucette GJ (2005)
Cytotoxic and cytoskeletal effects of azaspiracid-1 on mammalian
cell lines. Toxicon 45:891–900
6. Ito E, Satake M, Ofuji K, Kurita N, McMahon T, James KJ,
Yasumoto T (2000) Multiple organ damage caused by a new toxin
azaspiracid, isolated from mussels produced in Ireland. Toxicon
38:917–930
7. Miles CO, Wilkins AL, Munday R, Dines MH, Hawkes AD,
Briggs LR, Sandvik M, Jensen DJ, Cooney JM, Holland PT,
Quilliam MA, MacKenzie AL, Beuzenberg V, Towers NR (2004)
Isolation of pectenotoxin-2 from Dinophysis acuta and its
conversion to pectenotoxin-2 seco acid, and preliminary assess-
ment of their acute toxicities. Toxicon 43:1–9
8. Miles CO, Wilkins AL, Munday JS, Munday R, Hawkes AD,
Jensen DJ, Cooney JM, Beuzenberg V (2006) Production of 7-
epi-pectenotoxin-2 seco acid and assessment of its acute toxicity
to mice. J Agric Food Chem 54:1530–1534
9. Richard DJA, Arsenault E, Cembella AD, Quilliam MA (2000)
Investigations into the toxicology and pharmacology of spiro-
lides, a novel group of shellfish toxins. In: Hallegraeff GM,
Blackburn SI, Bolch CJ, Lewis RJ (eds) Intergovermental
Oceanographic Commission of UNESCO, 2001. Hobart, Aus-
tralia, pp 383–386
10. European Commission (2004) Commission Directive 2004/853/
EC Specific hygiene rules for food of animal origin. Off J Eur
Commun L226:22–82
11. Alexander J, Audunsson GA, Benford D, Cockburn A, Cradevi J-
P, Dogliotti E, Domenico AD, Fernandez-Cruz ML, Fink-
Gremmels J, Furst P, Galli C, Grandjean P, Gzyl J, Heinemeyer
G, Johansson N, Mutti A, Schlatter J, Rv L, Peteghem CV, Verger
P (2008) Marine biotoxins in shellfish—okadaic acid and
analogues. The EFSA Journal 589:1–62
12. Gerssen A, Mulder PPJ, McElhinney MA, De Boer J (2009)
Liquid chromatography—tandem mass spectrometry method for
the detection of marine lipophilic toxins under alkaline conditions.
J Chromatogr A 1216:1421–1430
13. Stobo LA, Lacaze JPCL, Scott AC, Gallacher S, Smith EA,
Quilliam MA (2005) Liquid chromatography with mass spec-
trometry—detection of lipophilic shellfish toxins. J AOAC Int
88:1371–1382
14. McNabb P, Selwood AI, Holland PT (2005) Multiresidue method
for determination of algal toxins in shellfish: single-laboratory
validation and interlaboratory study. J AOAC Int 88:761–772
15. Fux E, McMillan D, Bire R, Hess P (2007) Development of an
ultra-performance liquid chromatography–mass spectrometry
method for the detection of lipophilic marine toxins. J Chromatogr
A 1157:273–280
16. Ito S, Tsukada K (2002) Matrix effect and correction by standard
addition in quantitative liquid chromatographic-mass spectromet-
ric analysis of diarrhetic shellfish poisoning toxins. J Chromatogr
A 943:39–46
17. Jorgensen K, Jensen LB (2004) Distribution of diarrhetic shellfish
poisoning toxins in consignments of blue mussel. Food Addit
Contam 21:341–347
18. Furey A, Brana-Magdalena A, Lehna M, Moroney C, James KJ,
Satake M, Yasumoto T (2002) Determination of azaspiracids in
shellfish using liquid chromatography/tandem electrospray mass
spectrometry. Rapid Commun Mass Spectrom 16:238–242
19. Puente PF, Saez MJF, Hamilton B, Lehane M, Ramstad H, Furey
A, James KJ (2004) Rapid determination of polyether marine
toxins using liquid chromatography-multiple tandem mass spec-
trometry. J Chromatogr A 1056:77–82
20. Vale P, Sampayo MAD (2002) Esterification of DSP toxins by
Portuguese bivalves from the Northwest coast determined by LC–
MS - a widespread phenomenon. Toxicon 40:33–42
SPE for removal of matrix effects in lipophilic marine toxin analysis 1225
21. Van Loco J, Kotterman MJJ, Hess P (2008) Report on results of
the validation study (D29), within the 6th Framework project
‘BIOTOX: Development of cost-effective tools for risk manage-
ment and traceability systems for marine biotoxins in seafood’
Contract no: 514074
22. Puech L, Dragacci S, Gleizes E, Fremy JM (1999) Use of
immunoaffinity columns for clean-up of diarrhetic toxins (okadaic
acid and dinophysistoxins) extracts from shellfish prior to their
analysis by HPLC fluorimetry. Food Addit Contam 16:239–251
23. Quilliam MA (1995) Analysis of diarrhetic shellfish poisoning
toxins in shellfish tissue by liquid-chromatography with fluoro-
metric and mass-spectrometric detection. J AOAC Int 78:555–570
24. Goto H, Igarashi T, Yamamoto M, Yasuda M, Sekiguchi R, Watai
M, Tanno K, Yasumoto T (2001) Quantitative determination of
marine toxins associated with diarrhetic shellfish poisonning by
liquid chromatography coupled with mass spectrometry. J Chro-
matogr A 907:181–189
25. Moroney C, Lehane M, Brana-Magdalena A, Furey A, James KJ
(2002) Comparison of solid-phase extraction methods for the
determination of azaspiracids in shellfish by liquid chromatography-
electrospray mass spectrometry. J Chromatogr A 963:353–361
26. Fux E, Rode D, Bire R, Hess P (2008) Approaches to the
evaluation of matrix effects in the liquid chromatography-mass
spectrometry (LC–MS) analysis of three regulated lipophilic toxin
groups in mussel matrix (Mytilus edulis). Food Addit Contam
25:1024–1032
27. Hess P, McMahon T, Slattery D, Swords D, Dowling G,
McCarron M, Clarke D, Gibbons W, Silke J, O'Cinneide M
(2003) Use of LC–MS testing to identify lipophilic toxins, to
establish local trends and interspecies differences and to test the
comparability of LC–MS testing with the mouse bioassay: an
example from the Irish Biotoxin monitoring programme 2001. In:
Villalba A, Reguera A, Romalde JL, Beiras R (eds) Consellería de
Pesca e Asuntos Marítimos da Xunta de Galicia and Intergovern-
mental Oceanographic Commission of UNESCO, 2003. Santiago
de Compostela, Spain, pp 57–66
28. Quilliam MA, Hess P, Dell' Aversano C (2001) Recent develop-
ments in the analysis of phycotoxins by liquid chromatography-
mass spectrometry. In: de Koe WJ, Samson RA, van Egmond HP,
Gilbert J, Sabino M (eds) Mycotoxins and phycotoxins in
perspective at the turn of the century. Wageningen, The Nether-
lands, pp 383–391
1226 A. Gerssen et al.
